Bio-Techne (TECH)
71.68
+0.08 (0.11%)
Upcoming Events
Latest Headlines
TD Cowen reports short interest changes in life science stocks
July 27, 2026 12:15 PM - StreetInsider
Form DEFA14A BIO-TECHNE Corp
July 9, 2026 4:20 PM - SEC Filing
RBC Capital Downgrades Bio-Techne Corp. (TECH) to Sector Perform
July 9, 2026 2:07 AM - StreetInsider
Bio-Techne expands AI-engineered protein portfolio for cell therapy
July 8, 2026 6:30 AM - StreetInsider
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
July 8, 2026 6:30 AM - PR NewsWire
Evercore ISI Downgrades Bio-Techne Corp. (TECH) to In Line
July 6, 2026 5:58 AM - StreetInsider
Shareholder Alert: Ademi LLP investigates whether Bio-Techne Corporation is obtaining a Fair Price for Public Shareholders
July 2, 2026 5:32 AM - StreetInsider
Benchmark Downgrades Bio-Techne Corp. (TECH) to Hold
June 30, 2026 7:06 AM - StreetInsider
TD Cowen Downgrades Bio-Techne Corp. (TECH) to Hold
June 29, 2026 4:30 PM - StreetInsider
Stephens Downgrades Bio-Techne Corp. (TECH) to Equal Weight
June 26, 2026 8:24 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Raised to $73 at Baird
June 26, 2026 6:37 AM - StreetInsider
Form 8-K BIO-TECHNE Corp For: Jun 23
June 26, 2026 6:02 AM - SEC Filing
Deutsche Bank Downgrades Bio-Techne Corp. (TECH) to Hold
June 26, 2026 3:34 AM - StreetInsider
William Blair Downgrades Bio-Techne Corp. (TECH) to Market Perform
June 26, 2026 2:48 AM - StreetInsider
Form DEFA14A BIO-TECHNE Corp
June 25, 2026 4:46 PM - SEC Filing
Leerink Downgrades Bio-Techne Corp. (TECH) to Market Perform
June 25, 2026 11:22 AM - StreetInsider
Form 8-K BIO-TECHNE Corp For: Jun 25
June 25, 2026 8:21 AM - SEC Filing
Merck KGaA to acquire Bio-Techne for $11.3 billion
June 25, 2026 6:10 AM - StreetInsider
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
June 25, 2026 6:10 AM - PR NewsWire
TD Cowen Highlights Bio-Techne Corp. (TECH) as a Best Smidcap Idea
June 23, 2026 8:52 AM - StreetInsider
Activist Ananym builds stake in Bio-Techne, urges strategic review - Bloomberg
June 15, 2026 8:47 AM - StreetInsider
Piper Sandler Starts Bio-Techne Corp. (TECH) at Neutral
June 11, 2026 4:11 AM - StreetInsider
Form 4 BIO-TECHNE Corp For: Jun 02 Filed by: Crouse Steven C.
June 4, 2026 4:29 PM - SEC Filing
Bio-Techne and Refeyn launch integrated workflow for antibody analysis
June 4, 2026 6:31 AM - StreetInsider
Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
June 4, 2026 6:30 AM - PR NewsWire
Form SD BIO-TECHNE Corp
June 1, 2026 4:31 PM - SEC Filing
RBC Capital Assumes Bio-Techne Corp. (TECH) at Outperform
May 14, 2026 4:12 PM - StreetInsider
Form 4 BIO-TECHNE Corp For: May 08 Filed by: Herr Amy E.
May 12, 2026 4:04 PM - SEC Filing
Form 144 BIO-TECHNE Corp Filed by: Herr Amy E.
May 8, 2026 4:23 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Hippel James
May 7, 2026 5:26 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Bohnen Shane
May 7, 2026 5:25 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Kelderman Kim
May 7, 2026 5:22 PM - SEC Filing
Bio-Techne Corp. (TECH) PT Lowered to $62 at Wells Fargo
May 7, 2026 8:25 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Lowered to $50 at Stifel
May 7, 2026 7:30 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Lowered to $49 at Baird
May 7, 2026 7:11 AM - StreetInsider
Form 10-Q BIO-TECHNE Corp For: Mar 31
May 6, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G BIO-TECHNE Corp Filed by: FMR LLC
May 6, 2026 11:01 AM - SEC Filing
Bio-Techne (TECH) Misses Q3 EPS by 1c
May 6, 2026 6:33 AM - StreetInsider
Form 8-K BIO-TECHNE Corp For: May 06
May 6, 2026 6:31 AM - SEC Filing
Bio-Techne Releases Third Quarter Fiscal 2026 Results
May 6, 2026 6:30 AM - PR NewsWire
Bio-Techne Declares Dividend
May 6, 2026 6:30 AM - PR NewsWire
Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.6% Yield
May 6, 2026 6:30 AM - StreetInsider
Form 4 BIO-TECHNE Corp For: May 01 Filed by: Crouse Steven C.
May 5, 2026 4:13 PM - SEC Filing
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 4, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13G BIO-TECHNE Corp Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 5:01 PM - SEC Filing
Full Article List
